REVIEW
|
doi:10.20944/preprints202306.1788.v1
Subject:
Medicine And Pharmacology,
Medicine And Pharmacology
Keywords:
Meningioma; Cabozantinib; VEGF; Targeted treatment Cabozantinib; METs; VEGFR2; Inhibitors; Angiogen-esis; Oncology
Online: 26 June 2023 (10:57:00 CEST)